Record SIP Momentum Masks Profit Collapse
AUM surged 13% to ₹87.5 lakh crore and monthly SIP inflows hit ₹3,900 crore—all-time records—yet net profit cratered 20.3% quarter-over-quarter. The real story is margin compression, not growth.
₹701 Cr
-20.3% QoQ
₹864.8 Cr
prior quarter
₹1,193 Cr
+3.5% QoQ only
SBI Funds delivered record AUM growth and all-time-high SIP inflows, yet net profit fell a fifth quarter-over-quarter. Revenue grew just 3.5%—too small to offset a ₹27–28 crore cost spike that sent quarterly profit from ₹864.8 crore to ₹701 crore. The gap between momentum on the top line and collapse on the bottom line is the story of Q2.
The profit reconciliation
H1 FY27 operating profit was ₹1,797 crore, up 11% year-over-year—solid, but a miss against the 17% YoY growth reference management cited on the Q1 call. The prior quarter implied operating profit of ₹1,070–1,100 crore (backing into the ₹864.8 crore PAT on a ~78–80% conversion). Q2's collapse came from a combination of cost inflation and structural yield compression as AUM mix shifted toward lower-margin products and yields compressed from base effects.
Management's claims vs. what holds up
AUM growth 13% YoY to ₹87.5T is strong
Stable earnings despite market volatility
Operating profit +11% YoY
One-time cost inflation ₹27–28 Cr, moderation expected Q3
Market-leading 15% AUM share
Structural 50–60% recurring vs. 40–50% one-time cost split
Where the margin went
Management pinned the ₹27–28 crore Q2 cost spike to three buckets: (1) senior talent hires and AIF team expansion to deepen alternatives capability; (2) cloud infrastructure migration to modernize the tech stack; (3) AI-driven automation platform builds for investor onboarding (Aarambh). The company split the blame 50–60% recurring (base salary inflation, team headcount staying elevated) and 40–50% one-time (platform capex). If management is right, Q3 cost should drop 30–40% from Q2 peaks. If wrong—if ongoing strategic capex on AI, cloud, and AIF staffing persists—margin recovery will stall.
In fact, you have rightly pointed out this one-time investment in IT and human resources will be definitely moderated. It will be reduced to a large extent.
What changed on this call
Operating profit growth downshifted: the Q1 call referenced 17% YoY op. profit growth as a benchmark; H1 delivery came in at 11%, a material miss. Quarterly profit volatility (Q2 down 20.3% QoQ despite flat revenue) revealed the cost base to be less stable than disclosed. But product acceleration is real—management launched five new offerings in Q2 including infrastructure for Category III AIF, and B30 SIP contribution expanded to 65% of all SIP inflows. The trend in alternatives (AIF QAAUM +27% YoY to ₹7.4T) and digital adoption (InvesTap at 4.3M users, 94% digital transaction rate) is strong. The tension: near-term cost headwinds colliding with long-term growth tailwinds.
How the street is positioned
The stock is down 24.2% from its all-time high of ₹609.75, now trading at ₹462.05 on oversold technicals (RSI 28.6). It sits near the 52-week low of ₹434.75, a steep repricing. Institutional ownership is minimal: FII holds just 1.43%, DII 2.97%, leaving 88.19% with SBI (founder-promoter lock-in). The absence of institutional buying into this selloff signals skepticism on margin recovery timing. If the Q3 cost moderation materializes and AUM growth sustains, the current price may represent overshooting. If cost inflation persists, the stock could test lower.
Market-leading 15% AUM share, largest passive player
All-time-high monthly SIP flows at ₹3,900 Cr
B30 SIP penetration at 65%, reaching 98% of investors with 36+ month hold
Digital platform adoption at 94% and InvesTap scaling to 4.3M users
Operating margin at 76.5% reflects high-margin asset management model
Q2 PAT down 20.3% QoQ despite 3.5% revenue growth
Operating profit +11% YoY vs. 17% reference from prior call
Cost inflation unplanned; credibility on one-time vs. recurring split questioned
Revenue growth (3.5% QoQ) lagging AUM growth (13% YoY), signaling yield compression
FII/DII ownership at 1.43% / 2.97% signals institutional skepticism
Stock down 24% from ATH; oversold technicals (RSI 28.6) suggest capitulation
Cost inflation persists; margin recovery delayed
High₹27–28 Cr Q2 spike with 50–60% recurring base means structural margin compression. If Q3 moderation fails or ongoing strategic capex (AI, cloud, AIF team) persists, PAT growth remains capped and management credibility further erodes.
Quarterly PAT volatility signals earnings unpredictability
HighQ2 PAT ₹701 Cr down 20.3% QoQ from ₹864.8 Cr despite 3.5% revenue growth reveals cost base instability. Near-term earnings unpredictability creates valuation risk and may trigger further institutional selling.
AUM margin compression from asset-mix shift and yield pressure
MediumAUM +13% YoY but revenue only +3.5% QoQ. Shift toward lower-margin assets (liquid +27% YoY, passive +23% YoY, new SIF/AIF launches) and equity yield compression (~62–63 bps) dilute blended yield. Structural, not cyclical.
New product execution delays (Category III AIF, PMS-only, GIFT City)
MediumFive launches in Q2 are underway, but timelines are vague (coming 'months/days/couple of weeks'). Regulatory approvals, product-market fit, and team hiring all carry execution risk. If delayed, growth acceleration stalls.
Regulatory and competitive intensity in B30 / SIP distribution
MediumRevenue recognition pricing change (April 1) already in effect. Large PMS investor mandate relocated. B30 expansion is competitive; no unique moat on distribution. Field cost inflation to maintain market share may offset SIP volume gains.
1 · Q3 cost moderation: Is the 30–40% promised decline real?
Management promised operating cost to drop 30–40% in Q3 from the ₹27–28 Cr Q2 spike. Track Q3 absolute opex and sequential change. If moderation doesn't materialize or ongoing capex persists, the cost inflation is structural and margin recovery delays.
2 · Category III AIF and PMS-only product launches
New offerings are planned for H2 FY27. Track announcement timing, NFO inflows, early-stage AUM, and investor participation. These higher-margin categories are key to PAT growth acceleration and proof that alternatives scaling is revenue-generative.
3 · Operating margin stabilization trajectory
Q2 operating margin was 76.5%. If cost growth decelerates and revenue growth resumes in the high-single-digit range, OPM could recover toward 78–80% by Q4 FY27. Track H2 quarterly OPM as a leading indicator of PAT recovery.
4 · B30 SIP retention and unit economics
SIP contribution is 65% of inflows and management claims 98% of B30 customers hold >36 months. Monitor whether churn accelerates in market downturns and whether distribution cost per SIP increases materially. B30 unit economics are critical to long-term profitability.
SBI Funds is a market-leading, high-quality franchise caught in a cyclical margin trough. The structural growth drivers are intact: AUM expansion, SIP adoption, B30 deepening, and alternatives scaling are all visible and undeniable. But Q2 profit compression from unplanned cost inflation has eroded near-term credibility. Management's 17% YoY operating profit growth target from Q1 downshifted to 11% delivered—a material miss that raises questions about guidance reliability and cost control.
The stock has repriced sharply (down 24% from all-time high, oversold technicals at RSI 28.6) and institutional ownership is minimal, suggesting capitulation. The fundamental case hinges on whether management executes cost moderation in Q3 onward while sustaining AUM growth above 10% YoY. Until that happens—until adjusted operating profit stabilizes above ₹600 crore and cost growth decelerates visibly—the verdict remains Hold.
The single number to track: Q3 operating profit. If it bounces 30–40% from Q2 levels and the trend holds into Q4, the selloff becomes an opportunity. If not, the market's skepticism is justified.
Informational and educational content only. Not investment advice.